Related Experiment Videos
Fructose 2,6-bisphosphate in hypoglycemic rat brain
S Ambrosio1, F Ventura, J L Rosa
1Departament de Ciències Fisiològiques, Universitat de Barcelona, Spain.
Journal of Neurochemistry
|July 1, 1991
Summary
Fructose 2,6-bisphosphate levels decrease significantly in severe hypoglycemia, impacting brain function. This suggests a critical role for this metabolite in maintaining cerebral glycolysis during low blood sugar.
Area of Science:
- Biochemistry
- Neuroscience
- Metabolism
Background:
- Fructose 2,6-bisphosphate is a key regulator of glycolysis.
- Hypoglycemia can affect brain energy metabolism.
- Understanding metabolite changes during hypoglycemia is crucial for brain protection.
Purpose of the Study:
- To investigate the changes in cerebral fructose 2,6-bisphosphate levels during insulin-induced hypoglycemia.
- To correlate these changes with regional brain damage.
- To elucidate the role of fructose 2,6-bisphosphate in cerebral energy metabolism under hypoglycemic conditions.
Main Methods:
- Insulin-induced hypoglycemia in animal models.
- Measurement of fructose 2,6-bisphosphate and ATP levels in different brain regions (cortex, striatum, cerebellum, hippocampus).
- Analysis of metabolite changes during mild hypoglycemia, hypoglycemic coma, and recovery after glucose administration.
Main Results:
- No change in cerebral fructose 2,6-bisphosphate in mild hypoglycemia.
- Marked decrease in fructose 2,6-bisphosphate during hypoglycemic coma, with recovery after glucose administration.
- Severe hypoglycemia reduced fructose 2,6-bisphosphate levels uniformly across all analyzed brain regions.
- Decreased fructose 2,6-bisphosphate was not always paralleled by ATP reduction, suggesting impaired 6-phosphofructo-2-kinase activity due to low fructose 6-phosphate.
Conclusions:
- Fructose 2,6-bisphosphate levels are significantly reduced in severe cerebral hypoglycemia.
- The decrease is likely due to reduced 6-phosphofructo-2-kinase activity.
- Fructose 2,6-bisphosphate may play a permissive role in maintaining cerebral glycolysis and 6-phosphofructo-1-kinase activation.